1-7 of 7
Andrea Schnaiter, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cotargeting of PIM, PI3K and Mtor in Mantle Cell Lymphoma (MCL)

Free
Bianca Freysoldt, Andrea Schnaiter, MD, Luca Fischer, Michael O'Neill, PhD, Yvonne Zimmermann, Grit Hutter, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5120.
https://doi.org/10.1182/blood.V126.23.5120.5120
Published: 2015
Journal Articles

The Novel CDK4/6-Inhibitor Abemaciclib Induces Early G1-Arrest in MCL Cell Lines, Sensitizes Cells to Cytarabine Treatment and Is Additive with Ibrutinib

Free
Luca Fischer, Andrea Schnaiter, MD, Bianca Freysoldt, Markus Irger, Yvonne Zimmermann, Grit Hutter, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5124.
https://doi.org/10.1182/blood.V126.23.5124.5124
Published: 2015
Journal Articles

Telomere Length and Treatment Outcome In Chronic Lymphocytic Leukemia: Results From The CLL8 Trial

Free
Billy Michael Chelliah Jebaraj, PhD, Raymonde Busch, PhD, Thorsten Zenz, MD, Andreas Bühler, MD, Dirk Winkler, MD, Andrea Schnaiter, MD, Jennifer Edelmann, MD, Daniel Mertens, PhD, Sebastian Böttcher, MD, Michael Kneba, MD, Ulrich Jäger, MD, Michael K Wenger, MD, Guenter Fingerle-Rowson, MD PhD, Clemens Wendtner, MD, Anna-Maria Fink, MD, Kirsten Fischer, MD, Michael Hallek, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2013) 122 (21): 671.
https://doi.org/10.1182/blood.V122.21.671.671
Published: 2013
Journal Articles

SF3B1 , NOTCH1 and TP53 Mutations Do Not Affect the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 6-Year Follow-up of the Gcllsg CLL3X Trial

Free
Peter Dreger, MD, Andrea Schnaiter, MD, Marianna Rossi, Peter Paschka, Andreas Bühler, MD, Thorsten Zenz, MD, Sascha Dietrich, MD, Sebastian Böttcher, MD, Donald Bunjes, Michael Stadler, MD, Lutz Uharek, MD, Christof Scheid, MD, PhD, Ute Hegenbart, MD, Michael Hallek, MD, Michael Kneba, MD, PhD, Norbert Schmitz, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2012) 120 (21): 966.
https://doi.org/10.1182/blood.V120.21.966.966
Published: 2012
Journal Articles

Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial

Free
Stephan Stilgenbauer, MD, Raymonde Busch, Andrea Schnaiter, MD, Peter Paschka, Marianna Rossi, Konstanze Döhner, Thorsten Zenz, MD, Andreas Bühler, Dirk Winkler, Jennifer Edelmann, MD, Daniel Mertens, PhD, Lars Bullinger, MD, PhD, Sabrina Kless, Silja Mack, MSc, Sebastian Böttcher, MD, Matthias Ritgen, Michael Kneba, MD, PhD, Ulrich Jäger, MD, Peter Lichter, Nancy Patten, PhD., Michael K. Wenger, Myriam Mendila, MD, Gunter Fingerle-Rowson, MD, PhD, Mario Cazzola, Clemens Wendtner, Anna Maria Fink, MD, Kirsten Fischer, MD, Michael Hallek, MD, Hartmut Döhner
Journal: Blood
Blood (2012) 120 (21): 433.
https://doi.org/10.1182/blood.V120.21.433.433
Published: 2012
Journal Articles

NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg

Free
Andrea Schnaiter, MD, Marianna Rossi, Peter Paschka, Mario Cazzola, Konstanze Döhner, MD, Jennifer Edelmann, MD, Andreas Bühler, MD, Sabrina Kless, Daniel Mertens, PhD, Raymonde Busch, Silja Mack, MSc, Michael Hallek, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2012) 120 (21): 710.
https://doi.org/10.1182/blood.V120.21.710.710
Published: 2012
Journal Articles

Exceptional In Vitro Activity of CD37 Antibodies In CLL

Free
Thorsten Zenz, MD, Matthias Volden, Theresa Mast, Karsten Nordhausen, Dirk Winkler, MD, Andrea Schnaiter, MD, Andreas Buehler, MD, Karl-Heinz Heider, PhD, Volker Reichardt, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2010) 116 (21): 2460.
https://doi.org/10.1182/blood.V116.21.2460.2460
Published: 2010